Intradermal Delivery of Alopecia Therapeutics: Current State and Future Prospects

Author:

Alhanshali Lina1,Buontempo Michael2,Majerson Daniela3,Shapiro Jerry4,Lo Sicco Kristen4

Affiliation:

1. Department of Dermatology, SUNY Downstate College of Medicine, Brooklyn, New York

2. Department of Dermatology, Hackensack Meridian School of Medicine, Nutley, New Jersey

3. Pontificia Universidad Católica de Chile, Santiago, Chile;

4. Department of Dermatology, The Ronald O. Perelman, NYU Grossman School of Medicine, New York, New York

Abstract

BACKGROUND Mesotherapy, a technique of transdermal microinjections of specific preparations, is increasingly used in fields such as dermatology and specifically for alopecia treatment. Its popularity stems from its ability to deliver drugs in a targeted manner while minimizing systemic side effects. OBJECTIVE To assess and review current knowledge regarding the use of mesotherapy to deliver alopecia medications and highlight future directions for research. MATERIALS AND METHODS The authors used research databases including PubMed and Google Scholar to identify current literature on mesotherapy and alopecia. The following search terms were used among other terms: “Mesotherapy” or “Intradermal” AND “Alopecia”. RESULTS Recent studies are promising for the intradermal delivery of dutasteride and minoxidil in the treatment of androgenetic alopecia. CONCLUSION Although limitations exist with dutasteride and minoxidil therapies, further research regarding the preparation, delivery, and maintenance of these drugs is warranted as mesotherapy could establish this technique as a safe, effective, and viable treatment option for androgenetic alopecia.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Dermatology,General Medicine,Surgery

Reference19 articles.

1. What is mesotherapy? [article in French];Pistor;Chir Dent Fr,1976

2. Androgenetic alopecia;Otberg;Endocrinol Metab Clin North America,2007

3. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients;Vañó-Galván;J Am Acad Dermatol,2021

4. Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic review;Hirshburg;J Clin Aesthet Dermatol,2016

5. Current application of mesotherapy in pattern hair loss: a systematic review;Tang;J Cosmet Dermatol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3